Medicamen Biotech informs about board meeting

23 Jun 2020 Evaluate

Medicamen Biotech has informed that a Meeting of the Board of Directors of the Company is scheduled to be held on June 30, 2020, to consider and approve the Audited Financial Results of the Company (Standalone and Consolidated) for the quarter/ year ended on March 31, 2020; to consider the recommendation of Final Dividend for the FY 2019-20 on the Equity Shares of the Company, subject to approval of shareholders in the ensuing Annual General Meeting; to appoint SPB & Co, Cost Accountants, as the Cost Auditor of the company for the financial year 2020-21; to appoint Cheena & Associates, as the Internal Auditor of the company for the financial year 2020-21; to appoint AMJ & Associates, as the Secretarial Auditor of the company for the financial year 2020-21; and any other business with the permission of the chair. In this connection, to Company’s letter dated March 31, 2020, wherein it was informed that pursuant to the Company’s Code of Conduct framed in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015 and amendments made there under, the trading window for dealing in the shares of the Company is closed for all designated persons of the Company from the April 01, 2020 and will open 48 hours after the said Financial Results are declared to BSE.

The above information is a part of company’s filings submitted to BSE.

Medicamen Biotech Share Price

381.90 -8.35 (-2.14%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×